Home / Mepolizumab / Norway
NO ATC R03DX09 · updated 2 Nov 2026
Mepolizumab shortage in Norway
Is there a Mepolizumab shortage in Norway?
Yes. As of 2 Nov 2026, 1 Mepolizumab product is reported short in Norway, the first since 19 Oct 2026. The company estimate for the return is 13 Nov 2026. Main reason: distribution or logistics.
Also short in Italy. All countries.
Affected products in Norway
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| NO | Nucala 100 mg injeksjonsvæske, oppløsning i ferdigfylt sprøyte, 1 ml ferdigfylt sprøyte | GlaxoSmithKline Trading Services Limited | 19 Oct 2026 | 13 Nov 2026 | Distribution or logistics Distribusjonsproblemer |
Source
DMP (Norwegian Medical Products Agency). Official list. Ongoing and announced shortages reported by companies; one row per pack (varenummer).